Table 3.

Summary of recommendations for patients with microalbuminuriaa

Renoprotection with ACE inhibitors or angiotensin receptor blockers for patients with diabetes
BP control
    <140/90 mmHg for the general population
    <130/80 mmHg for patients with diabetes
Glycemic control: hemoglobin A1c <7%
Consider screening in patients with diabetes
LDL cholesterol control for diabetes in the general population
    <100 mg/dl (<2.6 mmol/L) for patients with or without diabetes
    <70 mg/dl (<1.8 mmol/L) for patients with CVD
Correct disturbances in triglyceride, HDL, and non-HDL levels
Smoking cessation
Dietary limitation of salt (<3 g/d) and saturated fat
Regular exercise and weight control
Antiplatelet therapy
  • a ACE, angiotensin-converting enzyme.